Xiaoyang Zhai
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Association of salvage radiotherapy with survival outcomes in extracranial oligoprogression after first-line therapy for extensive-stage small-cell lung cancer: a multicenter retrospective cohort study.
Journal: Therapeutic advances in medical oncology
Published: March 01, 2026
Comparison of concurrent chemoradiotherapy followed by immunotherapy and induction chemoimmunotherapy followed by radiotherapy in unresectable stage III NSCLC: a retrospective cohort study.
Journal: Future oncology (London, England)
Published: February 27, 2026
Restoring osimertinib sensitivity in EGFR-mutant NSCLC: the role of anlotinib in modulating Wnt/β-catenin/YAP pathways.
Journal: American journal of cancer research
Published: September 06, 2025
Remarkable response to Osimertinib plus Gumarontinib for EGFR mutation and concomitant MET exon 14 skipping in a patient with lung adenocarcinoma: A case report.
Journal: Oncology letters
Published: June 03, 2025
Impact of delayed addition of PD-1/PD-L1 inhibitors to chemotherapy on outcomes in patients with extensive-stage small cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: April 22, 2025
Virus-Inspired Nanoparticles for Intensified Cancer Therapy via Cascade Reinforcement of "Nontoxicity-to-Toxicity" Transition and Mitochondrial Dysfunction.
Journal: Advanced healthcare materials
Published: December 29, 2024
Macrophages in the premetastatic and metastatic niche: key functions and therapeutic directions.
Journal: Journal of translational medicine
Published: December 28, 2024
Comparison of neoadjuvant chemoimmunotherapy with planned surgery and concurrent chemoradiation followed by immunotherapy for potentially resectable stage III non-small-cell lung cancer: a retrospective study.
Journal: Cancer immunology, immunotherapy : CII
Published: October 15, 2024
Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases.
Journal: Cancer letters
Published: May 16, 2024
Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases.
Journal: Journal of neuro-oncology
Published: July 25, 2023
Last Updated: 09/26/2026